Not recruiting yet
Total Hip Replacement: an Investigation of Robotic-assisted Versus conVentional Surgery and Patient-centred outcomEs
NCT07907185 · Hamilton Health Sciences Corporation · Updated 30 Oct 2026
- What is being tested
- MAKO Robotic System (Stryker, USA); Conventional Total Hip Arthroplasty
- For
- Osteo Arthritis Knee and Hip
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 90 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started Jan 2027, ends Sept 2029. Registered 30 Oct 2026.
- Results
- None posted yet.
In the researchers' words
Hip replacement is highly effective for severe osteoarthritis, but some patients continue to experience symptoms or complications. Robotic-assisted hip replacement uses three-dimensional planning and robotic guidance to position implants more precisely. Although its use is increasing, it remains uncertain whether this added precision improves recovery or outcomes that patients can feel. We will conduct an internal pilot randomized trial of adults undergoing hip replacement at Juravinski Hospital. Participants will be assigned by chance to robotic-assisted or conventional surgery. The pilot will assess recruitment, delivery of assigned surgery, protocol adherence, follow-up and data quality to determine whether a larger Canadian multicentre trial is feasible. We will also collect joint awareness, function, quality of life, satisfaction, complications, operating time, length of stay and readmission. If progression criteria are met, pilot participants and data will be retained in the expanded trial. This study will build the Canadian evidence needed to evaluate robotic-assisted hip replacement responsibly.
